Related Experiment Video
Updated: May 13, 2026
08:52
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
3.0K
Cardamonin inhibits osteogenic differentiation by downregulating Wnt/beta-catenin signaling and alleviates
Fanding Meng1, Pengchong Zhu2, Xiaoli Ren3
1Department of Hand and Foot Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
Summary
Cardamonin (CD) alleviates osteoarthritis by inhibiting subchondral osteosclerosis and downregulating Wnt/β-catenin signaling. This natural compound protects cartilage and bone in OA mouse models, offering therapeutic potential.
Area of Science:
- Biomedical Science
- Pharmacology
- Orthopedics
Background:
- Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by subchondral osteosclerosis in later stages.
- Cardamonin (CD), a natural flavonoid from Alpinia katsumadai, exhibits anti-inflammatory properties.
- Subchondral osteosclerosis is a key pathological feature in advanced OA requiring therapeutic intervention.
Purpose of the Study:
- To investigate the therapeutic effects of Cardamonin (CD) on subchondral osteosclerosis in osteoarthritis (OA).
- To elucidate the underlying molecular mechanisms of CD in regulating OA pathology in vivo and in vitro.
- To assess CD's impact on cartilage metabolism and Wnt/β-catenin signaling in OA models.
Main Methods:
- Anterior cruciate ligament transection (ACLT) induced OA mouse model treated with varying doses of CD.
- Histological and immunohistochemical analyses of articular cartilage and subchondral bone markers.
- Microcomputed tomography (micro-CT) for subchondral bone sclerosis assessment.
- In vitro studies using MC3T3-E1 preosteoblast cells treated with CD to evaluate osteogenic differentiation and signaling pathways.
Main Results:
- CD treatment in OA mice preserved hyaline cartilage integrity, reduced calcified cartilage thickness, and decreased Osteoarthritis Research Society International (OARSI) scores.
- CD significantly inhibited subchondral osteosclerosis in the OA mouse model.
- In vitro, CD suppressed alkaline phosphatase, calcium nodule formation, and key osteogenic differentiation markers.
- CD downregulated the expression of Wnt/β-catenin pathway proteins in osteogenic differentiation.
Conclusions:
- Cardamonin (CD) demonstrates significant therapeutic potential in alleviating osteoarthritis and inhibiting subchondral osteosclerosis.
- CD exerts its effects by suppressing osteogenic differentiation through the downregulation of the Wnt/β-catenin signaling pathway.
- These findings highlight CD as a promising natural compound for managing OA-related bone pathology.
Related Concept Videos
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
01:23Catenins
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...